| Serial Number | 87449309 |
| Word Mark | DIMENSION THERAPEUTICS |
| Filing Date | Monday, May 15, 2017 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 10, 2018 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 13, 2018 |
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| Goods and Services | Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo laboratory use in gene therapy |
| Goods and Services | Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders |
| Goods and Services | Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; diagnostics services in the field of equipment used for gene therapy design and delivery; gene therapy design and delivery development of biochemical assays |
| Goods and Services | Providing medical services, namely, gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; dispensing of pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 18, 2017 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 18, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 18, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 18, 2017 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Dimension Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Dimension Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Monday, December 10, 2018 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 10, 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, May 8, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 13, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 13, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 21, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 7, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 7, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, February 7, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 7, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 7, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 14, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, August 14, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, August 14, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, August 14, 2017 | ASSIGNED TO EXAMINER |
| Thursday, May 18, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, May 18, 2017 | NEW APPLICATION ENTERED IN TRAM |